Triple receptor agonists have the potential to further bridge the efficacy gap in WL between BS and the currently approved obesity pharmacotherapies, with the added potential for other synergistic metabolic benefits, such as improving glycaemia in people with T2D, and treating or preventing MASLD/MASH
Chronic inflammation is a key contributor to various health issues, including cardiovascular disease
A persons genetics, skin type and health shape their response to UV exposure
In studies of Ozempic for type 2 diabetes, 20.3% of participants taking a 1-milligram (mg) dose of Ozempic reported feeling nauseous, compared to 6.1% of those given a placebo
It is an ongoing component of a thoughtful semaglutide protocol
Given the high prevalence of medical and psychiatric conditions in autistic individuals, they are likely to have increased AC exposure throughout their lifespan